← Eichor
Study identifier: NCT05864157 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease

Condition: Parkinson Disease  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseNA
Planned participants45
Who can joinAll sexes, 50 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this research study is to determine how training to step with a metronome on both a treadmill, as well as overground, will influence the way that people with Parkinson disease walk. Using metronomes is commonly used in clinics, but the investigators will be using a combination of slow and fast frequencies to alter the way that people walk. The use of a slower frequency metronome on the treadmill is intended to help participants take larger steps. The use of a faster frequency metronome while walking overground is intended to help participants take faster steps.This will take place over 12 training sessions. Each session will be about an hour. It will include some walking tests and pictures of the brain (using MRI) before and after training.

This description comes directly from the study's public registry record.

Talk to the study team

Mike Lewek, PT, PhD  ·  919-966-4041  ·  mlewek@med.unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05864157